Aptamers

Search for publications

Only original articles, editorials, guidelines.

  • Sánchez-Gil MA, Fraile-Martinez O, García-Montero C, Toledo MDV, Guijarro LG, De León-Luis JA, Bravo C, Díaz-Pedrero R, López-Gonzalez L, Saez MA, Álvarez-Mon M, García-Honduvilla N, Ortega MA.

    Histopathological Clues of Enhanced Inflammation in the Placental Tissue of Women with Chronic Venous Disease in Lower Limbs during Pregnancy.

    Journal of Personalized Medicine . 14(1): .

    [doi:10.3390/jpm14010087]

  • Cilleros-Rodríguez D, Toledo-Lobo MV, Martínez-Martínez D, Baquero P, Angulo JC, Chiloeches A, Iglesias T, Lasa M.

    Protein kinase D activity is a risk biomarker in prostate cancer that drives cell invasion by a Snail/ERK dependent mechanism.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1870(1): 166851-166851.

    [doi:10.1016/j.bbadis.2023.166851]

  • García-Fernández J, Rivadulla Costa L, Pinto-Díez C, Elena Martín M, González VM, de la Fuente Freire M.

    Chemical conjugation of aptamer-sphingomyelin nanosystems and their potential as inhibitors of tumour cell proliferation in breast cancer cells.

    Nanoscale . 15(47): 19110-19127.

    [doi:10.1039/d3nr03022a]

  • Mulens-Arias, Vladimir, Portilla, Yadileiny, Perez-Yaguee, Sonia, Ferreras-Martin, Raquel, Martin, M. Elena, Gonzalez, Victor M., Barber, Domingo F..

    An electrostatically conjugated-functional MNK1 aptamer reverts the intrinsic antitumor effect of polyethyleneimine-coated iron oxide nanoparticles in vivo in a human triple-negative cancer xenograft

    Cancer Nanotechnology . 14(1): .

    [doi:10.1186/s12645-023-00204-8]

  • Guijarro LG, Justo Bermejo FJ, Boaru DL, De Castro-Martinez P, De Leon-Oliva D, Fraile-Martínez O, Garcia-Montero C, Alvarez-Mon M, Toledo-Lobo MDV, Ortega MA.

    Is Insulin Receptor Substrate4 (IRS4) a Platform Involved in the Activation of Several Oncogenes?

    Cancers . 15(18): .

    [doi:10.3390/cancers15184651]

  • Hernández-Jiménez M, Abad-Santos F, Cotgreave I, Gallego J, Jilma B, Flores A, Jovin TG, Vivancos J, Hernández-Pérez M, Molina CA, Montaner J, Casariego J, Dalsgaard M, Liebeskind DS, Cobo E, Castellanos M, Portela PC, Masjuán J, Moniche F, Tembl JI, Terceño Izaga M, Arenillas JF, Callejas P, Olivot JM, Calviere L, Henon H, Mazighi M, Piñeiro D, Pugliese M, González VM, Moro MA, Garcia-Tornel A, Lizasoain I, Ribo M.

    Safety and Efficacy of ApTOLL in Patients With Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial.

    JAMA NEUROLOGY . 80(8): 779-788.

    [doi:10.1001/jamaneurol.2023.1660]

  • Robledo SM, Pérez-Silanes S, Fernández-Rubio C, Poveda A, Monzote L, González VM, Alonso-Collado P, Carrión J.

    Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

    PATHOGENS . 12(7): .

    [doi:10.3390/pathogens12070939]

  • Babiy B, Ramos-Molina B, Ocaña L, Sacristán S, Burgos-Santamaría D, Martínez-Botas J, Busto R, Perna C, Frutos MD, Albillos A, Pastor Ó.

    Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS . 1868(7): 159318-159318.

    [doi:10.1016/j.bbalip.2023.159318]

  • Colmenares R, Carrión-Marchante R, Martín ME, Salinas Muñoz L, García-Bermejo ML, Oller JC, Muñoz A, Blanco F, Rosado J, Lozano AI, Álvarez S, García-Vicente F, García G.

    Dependence of Induced Biological Damage on the Energy Distribution and Intensity of Clinical Intra-Operative Radiotherapy Electron Beams.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 24(13): .

    [doi:10.3390/ijms241310816]

  • Sánchez-Trujillo L, Fraile-Martinez O, García-Montero C, García-Puente LM, Guijarro LG, De Leon-Oliva D, Boaru DL, Gardón-Alburquerque D, Del Val Toledo Lobo M, Royuela M, García-Tuñón I, Rios-Parra A, De León-Luis JA, Bravo C, Álvarez-Mon M, Bujan J, Saez MA, García-Honduvilla N, Ortega MA.

    Chronic Venous Disease during Pregnancy Is Related to Inflammation of the Umbilical Cord: Role of Allograft Inflammatory Factor 1 (AIF-1) and Interleukins 10 (IL-10), IL-12 and IL-18.

    Journal of Personalized Medicine . 13(6): .

    [doi:10.3390/jpm13060956]

  • Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME.

    An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.

    Pharmaceutics . 15(4): .

    [doi:10.3390/pharmaceutics15041273]

  • Ortega MA, De Leon-Oliva D, Garcia-Montero C, Fraile-Martinez O, Boaru DL, Del Val Toledo Lobo M, García-Tuñón I, Royuela M, García-Honduvilla N, Bujan J, Guijarro LG, Alvarez-Mon M, Alvarez-Mon MÁ.

    Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease.

    GENES . 14(4): .

    [doi:10.3390/genes14040915]

  • Orea MJ, Angulo JC, González-Corpas A, Echegaray D, Marvá M, Lobo MVT, Colás B, Ropero S.

    Claudin-3 Loss of Expression Is a Prognostic Marker in Castration-Resistant Prostate Cancer.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 24(1): .

    [doi:10.3390/ijms24010803]

  • Moreno M, García-Sacristán A, Martín ME, González VM.

    Enzyme-Linked Oligonucleotide Assay (ELONA).

    Methods in molecular biology (Clifton, N.J.) . 2570: 235-242.

    [doi:10.1007/978-1-0716-2695-5_18]

  • Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME.

    Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer.

    Cancers . 15(1): .

    [doi:10.3390/cancers15010227]

  • Pinto-Díez C, Ferreras-Martín R, Carrión-Marchante R, Klett-Mingo JI, García-Hernández M, Pérez-Morgado MI, Sacristán S, Barragán M, Seijo-Vila M, Tundidor I, Blasco-Benito S, Pérez-Gómez E, Gómez-Pinto I, Sánchez C, González C, González VM, Martín ME.

    An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer.

    MOLECULAR THERAPY-NUCLEIC ACIDS . 30: 553-568. Number of citations: 4

    [doi:10.1016/j.omtn.2022.11.009]

  • Arriba MC, Fernández G, Chacón-Solano E, Mataix M, Martínez-Santamaría L, Illera N, Carrión-Marchante R, Martín ME, Larcher F, González VM, Del Río M, Carretero M.

    FORMYL PEPTIDE RECEPTOR 2 DNA APTAMERS FOR TARGETED THERAPY OF WOUND REPAIR.

    The Journal of investigative dermatology . 142(8): 2238. Number of citations: 1

    [doi:10.1016/j.jid.2021.12.026]

  • Hernández-Jiménez M, Martín-Vílchez S, Ochoa D, Mejía-Abril G, Román M, Camargo-Mamani P, Luquero-Bueno S, Jilma B, Moro MA, Fernández G, Piñeiro D, Ribó M, González VM, Lizasoain I, Abad-Santos F.

    First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers.

    MOLECULAR THERAPY-NUCLEIC ACIDS . 28: 124-135. Number of citations: 1

    [doi:10.1016/j.omtn.2022.03.005]